Cell therapy: cGMP facilities and manufacturing

Muscles, Ligaments and Tendons Journal

Volumn 2, Issue 3, 2012, Pages 243-247

  Giancola, Raffaella ^a   Bonfini, Tiziana ^a   Iacone, Antonio ^a  

^a Ospedale Civile di Pescara   (Italy)

Author keywords

Manufacturing; MSC; Tissue engineering

Indexed keywords

EID: 84892896329     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Tiede MA Stem Cell: applications and opportunities in drug discovery. Drug Discov World 2009;10:9-16.
2. Razvi ES, Oosta GM. Stem Cells for cellular therapy space. Drug Discov Today 2010;11:37-40.
3. McNeil S. Progress and opportunities for tissue engineering skin. Nature 2007;445:974-880.
4. Getgood A, Brooks R Fortier L, Rusthon N. Articular cartilage tissue engineering: today's research tomorrw's practice? J Bone Joint Surg Br 2009;91B:565-576.
5. Ahrund-Richter L, De Luca M, Marshak DR et al. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009;4:20-26.
6. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. Stem cells. Setting standards for human embryonic stem cells. Science 2003;300(5621):913-916.
7. Rubio D, Garcia-Castro J, Martin MC et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65(8):3035-3039.
8. Suter DM, Preynat-Seauve O, Tirefort D et al. Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells. J Cell Mol Med 2009;13(9B):3517-3527.
9. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858):1917-1920.
10. Lowry WE, Richter L, Yachechko R, Pyle AD et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. PNAS.;105(8):2883-2888.
11. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324(5928):797-801.
12. EMEA/CHMP 2006. Guideline on human cell-based medicinal products. EMEA/CHMP/410869/2006.
13. Dietz AB, Padley DJ, Gastineau DA. Infrastructure development for human cell therapy translation. Clin Pharmacol Ther 2007; 82: 320-324.
14. Good Manufacturing Practice for Pharmaceuticals Manufactures. www.gmp-quality.com.
15. FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration (Foundation for the Accreditation of Cellular Therapy (FACT-Joint Accreditation Committee of International Society of Cellular Therapy (ISCT) and European Group of Blood and Marrow transplantation (EBMT) (JACIE). www.factwebsite.org
16. Cellular and Gene Therapy Products. US Food and Drug Administration. www.fda.gov
17. EU Guidelines: Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Annex 1. Manufacture of Sterile Medicinal Products, 2009 (corrected version).
18. The International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. www.ich.org/cache/compo/276-254-1htlm.
19. EMEA/CHMP 2005. Guidelines on risk management systems for medicinal products for human use. EMEA/CHMP/96268/2005.
20. Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No726/2004.
21. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use.
22. European Pharmacopoeia (EurPh). www.aemps.es./ profHumana/farmacopea/doscs/index_5-3edic.pdf
23. The United States Pharmacopoeia (USP) www.usp.org/
24. Directive 2004/EC of the European Parliament and of the Council of 31 March 2004 on setting standards quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells.
25. Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells.
26. Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reaction and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells.
27. Ph. Eur. Text 5.1.6. (2008) Alternative methods for control of microbiological quality (01/2008:50106) and General Methods 2.6.27: Microbiological control of cellular products.
28. United States Food and Drug Administration. Validation of Growth-Based Rapid Microbiological Methods for Sterility Testing of Cellular and Gene Therapy Products. Rockville: Guidance for Industry (Draft), 2008.
29. EMEA/CPMP Point to consider on application with one pivotal clinical study (CPMP/EWP/2330/1990).
30. Proposed approach to regulation of cellular and tissue-based products. FDA www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/ Tissue/ UCM062601.pdf
31. C.F.R. 1271 (2006). Part 1271-Human Cells, Tissues, And Cellular And Tissue-Based Products www.access.gpo.gov%2Fnara%2 Fcfr%2Fwaisidx_ 06%2F21cfr1271_06.
32. Halme DG, Kessler DA: FDA Regulation of Stem-Cell-Based Therapies. N Engl J Med 2006, 355:1730-1735.
33. Fink DW. FDA Regulation of Stem-Cell-Based Products. Science 2009; 324:1662-1663.
34. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG: Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008, 25:E2
35. A Catalyst for Cures: Embryonic Stem Cell Research. The Coalition for the Advancement of Medical Research http//camradvocacy.org/resources/camr_wp.pdf.
36. Rao M, Condic ML. Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. Stem Cells Dev 2008;17:1-10.
37. Hyun I. The bioethics of stem cell research and therapy. J Clin Invest 2010, 120:71-75.
38. Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008, 3:607-609.
39. International Consortium of Stem Cell Networks: Global Regulation of Human Embryonic Stem Cell Research and Oocyte Donation www.stemcellcentre. edu.au/.
40. Rao M, Condic ML. Musings on genome medicine: is there hope for ethical and safe stem cell therapeutics? Genome Med 2009, 1:70.
41. Sommer CA, Mostoslavsky G. Experimental approaches for the generation of induced pluripotent stem cells. Stem Cell Res Ther 2010,1:26.
42. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
43. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
44. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49.
45. 2008 Amendments to the National Academies' guidelines for human embryonic stem cell research National Research Council and Institute of Medicine www.nap.edu/openbook.php?record_id =12260&page = 1
46. Canadian Updated Guidelines for Human Pluripotent Stem Cell Research, June 30, 2010 Please note: these Updated Guidelines for Human Pluripotent Stem Cell Research supersede the June 2007 version. www.cihr-isrc.gc.ca/
47. UK guidelines Human Fertilisation and Embryology Act 1990 and Human Fertilisation and Embryology Act 2004 www.legislation.gov.uk/uksi/2004/1511/
48. UK guidelines SCAG (02/08) 04 Human Fertilisation and Embryology Act 2008 www.dh.gov.uk/en/.../Legislation/ Actsandbills/DH_080211
49. Zarzeczn/ A, Scott C, Hyun I, Bennett J, Chandler J et al. iPS cells: mapping the policy issues. Cell 2009 Dec 11;139(6):1032-1037.
50. Global Summit of National Bioethics Advisory Bodies www.who.int/ethics/globalsummit
51. European Conference of National Ethics Comittees www.coe.int/t/dg3/healthbioethic/
52. International Bioethics Commitee www.unesco.org/ new/ en/ social-and-human-sciences/ themes/ bioethics/ international-bioethics-committee/